David C. Hastings

David C. Hastings

Former Chief Financial OfficeratArbutus Biopharma· In proxies 2023–2025

Pay in FY2025Arbutus Biopharma stock +47.1% the same year

David C. Hastings was paid $2.2M in FY2025 (Dec). Arbutus Biopharma stock rose 47.1% that year.

Pay$100 in the stock at the end of FY22 → $158
Pay is from the Summary Compensation Table of each Arbutus Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arbutus BiopharmaPublic company · 3 yr
    • Former Chief Financial Officer2023 – Present · 3 yrStock in role +85%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?